Abstract:X-ray computed tomography (CT) is one of the most powerful noninvasive diagnostic imaging techniques in modern medicine. Nevertheless, the iodinated molecules used as CT contrast agents in the clinic have relatively short circulation times in vivo, which significantly restrict the applications of this technique in target-specific imaging and angiography. In addition, the use of these agents can present adverse. For example, an adult patient typically receives approximately 70 mL of iodinated agent (350 mg I/mL) because of iodine's low contrast efficacy. Rapid renal clearance of such a large dose of these agents may lead to serious adverse effects. Furthermore, some patients are hypersensitive to iodine. Therefore, biomedical researchers have invested tremendous efforts to address these issues. Over the past decade, advances in nanoscience have created new paradigms for imaging. The unique properties of nanomaterials, such as their prolonged circulating half-life, passive accumulation at the tumor sites, facile surface modification, and integration of multiple diverse functions into a single particle, make them advantageous for in vivo applications. However, research on the utilization of nanomaterials for CT imaging has lagged far behind their applications for other imaging techniques such as MRI and fluorescence imaging because of the challenges in the preparation of cost-effective nanoparticulate CT contrast agents with excellent biocompatibility, high contrast efficacy, long in vivo circulation time, and long-term colloidal stability in physiological environments. This Account reviews our recent work on the design and in vivo applications of nanoparticulate CT contrast agents. By optimizing the contrast elements in the nanoparticles according to the fundamental principles of X-ray imaging and by employing the surface engineering approaches that we and others have developed, we have synthesized several nanoparticulate CT contrast agents with excellent imaging performance. For example, a novel Yb-based nanoparticulate agent provides enhanced contrast efficacy compared to currently available CT contrast agents under normal operating conditions. To deal with special situations, we integrated both Ba and Yb with great differential in K-edge value into a single particle to yield the first example of binary contrast agents. This agent displays much higher contrast than iodinated agents at different voltages and is highly suited to diagnostic imaging of various patients. Because of their prolonged in vivo circulation time and extremely low toxicity, these agents can be used for angiography.

Nanoparticle Contrast Agents for Dark-Field X-ray Imaging

Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications.

Simulation Research of Potential Contrast Agents for X-Ray Fluorescence CT with Photon Counting Detectors

Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance

Advances in Multifunctional Nano-Sized CT Contrast Agents

Nanoscale Dark-Field Imaging in Full-Field Transmission X-Ray Microscopy

Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography

Nano/Microparticles And Ultrasound Contrast Agents

Single-Irradiation Simultaneous Dual-Modal Bioimaging Using Nanostructure Scintillators as Single Contrast Agent.

High-Perform Yb-Based Nanoparticulate X-Ray CT Contrast Agent

Recent Advances In Ytterbium-Based Contrast Agents For In Vivo X-Ray Computed Tomography Imaging: Promises And Prospects

Toward the Clinical Translation of Safe Intravenous Long Circulating Iodinated Lipid Nanoemulsion Contrast Agents for CT Imaging

Contrast-enhanced photon-counting micro-CT of tumor xenograft models

WE‐E‐204B‐06: Imaging Characterization of Nanoparticles in Micro CT System

Nanomaterial-based CT contrast agents and their applications in image-guided therapy

Advances in Nano-Scale Metal-Based Contrast Agents for Computed Tomography: A Systematic Review

Single-shot X-ray Dark-field Tomography

Enhancing biomedical imaging: the role of nanoparticle-based contrast agents

Surface modification effect on contrast agent efficiency for X-ray based spectral photon-counting scanner/luminescence imaging: from fundamental study to in vivo proof of concept